Astria Therapeutics (ATXS) PT Raised to $30 at Oppenheimer on Reverse Stock Split
Tweet Send to a Friend
Oppenheimer analyst Hartaj Singh raised the price target on Astria Therapeutics (NASDAQ: ATXS) to $30.00 (from $5.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
